SOLVENTUM CORP (SOLV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SOLV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SOLV | Chair of the Board; Chair of the board | 68 | ["Former Chief Executive Officer, Humacyte, Inc.", "30 years of experience in leadership roles and member of multiple boards at healthcare companies", "Pharmaceutical and biotech executive experience including as CEO of a regenerative medicine company", "Significant experience as a seasoned executive and audit committee member", "Service on the boards and senior executive roles at global healthcare companies", "Deep experience in guiding companies undergoing significant transitions, including recently spun-off companies, as well as in M&A transactions", "Deep experience at head of drug and biotech development companies; Responsible for significant capital and R&D investments", "Management responsibility of a large multinational company operating in a regulated industry", "Roles including oversight of sales plans, marketing and brand for large global companies", "Significant experience as chair of board at multiple public and private companies with oversight over risk", "Notable compensation committee expertise"] | ["TC", "STQC", "Talent", "Science, Technology and Quality"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OGN | Executive Chair of the Board; Chairman of the Board | 68 | ["Executive Chair of Organon & Co.","Former Chief Executive Officer of Humacyte, Inc.","Former EVP of Schering-Plough","Current Chairman of Solventum Corporation","Director of Texas Instruments Inc.","Chief Executive Officer of Humacyte, Inc. (2010-2018)","Chairman of Humacyte's board (2013-2019)","Executive Vice President of Schering-Plough Corporation (2003-2009)","President of Schering-Plough’s global pharmaceutical business (2003-2009)","President of Pharmacia Corporation's global pharmaceutical business (1997-2003)","Chairman of the board of directors of Solventum Corporation"] | [] | 2026 |
| TXN | Director; Former chairman and chief executive officer of Humacyte, Inc. | 66 | ["Multinational experience","Executive leadership (public or private)","Technology, research and development","Financial acumen","Sustainability","Management responsibility of a large multinational company operating in a regulated industry","Responsibility for significant capital and R&D investments"] | ["AuditCommittee"] | 2024 |
| CAH | Chair of the Human Resources and Compensation Committee | [] | ["Human Resources and Compensation Committee", "Governance and Sustainability Committee"] | 2023 |
Biography sourced from the proxy statement filing.
Professional experience Organon & Co. Executive Chairman (2025 present) Humacyte, Inc. Chair of the Board (2013 2019) Board Member (2013 2021) Chief Executive Officer (2010 2018) Schering-Plough Corporation Executive Vice President and President of global pharmaceutical business (2003 2009) Pharmacia Corporation President of global pharmaceutical business (1997 2003) Carrie S. Cox 68 Director since 2024 Chair of the board Board committees Talent; Science, Technology and Quality Current public company directorships Organon & Co. (2021 - Present) Texas Instruments Inc. (2010 - Present) Prior public company directorships Cardinal Health Inc. (2009 -2023) Cartesian Therapeutics, Inc. (2019 - 2025) Skills and experience supporting nomination Ms. Cox brings substantial experience in guiding companies undergoing significant transitions, including recently spun-off companies, as well as in merger and divestiture transactions. With strong experience as a pharmaceutical company executive, she is an experienced leader at both the management and director levels. Healthcare Industry 30 years of experience in leadership roles and member of multiple boards at healthcare companies Executive Leadership Pharmaceutical and biotech executive experience including as CEO of a regenerative medicine company Financial Acumen & Experience Significant experience as a seasoned executive and audit committee member International & Global Operations Service on the boards and senior executive roles at global healthcare companies Strategy & M&A Deep experience in guiding companies undergoing significant transitions, including recently spun-off companies, as well as in M&A transactions Science, Technology, Research & Innovation Deep experience at head of drug and biotech development companies; Responsible for significant capital and R&D investments Quality, Regulatory & Compliance Management responsibility of a large multinational company operating in a regulated industry Corporate Sales, Marketing & Brand Management Roles including oversight of sales plans, marketing and brand for large global companies Risk Management Significant experience as chair of board at multiple public and private companies with oversight over risk Human Capital Management Notable compensation committee expertise